tiprankstipranks
Antisense Therapeutics Limited (ATHJF)
OTHER OTC:ATHJF

Antisense Therapeutics Limited (ATHJF) Ownership - Who Owns Antisense Therapeutics Limited?

12 Followers

Antisense Therapeutics Limited (ATHJF) Ownership Overview

2.34%0.00%0.00%97.66%
2.34%
Insiders
0.00% Other Institutional Investors
97.66% Public Companies and
Individual Investors
The ownership structure of Antisense Therapeutics Limited (ATHJF) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 2.34% is owned by Insiders and 97.66% is owned by Public Companies and Individual Investors.
The ownership structure of Antisense Therapeutics Limited (ATHJF) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 2.34% is owned by Insiders and 97.66% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,090,201Insider1.01%436,330
4,893,722Insider0.54%234,899
2,568,750Insider0.28%123,300
1,099,243Insider0.12%52,764
1,000,000Insider0.11%48,000
999,805Insider0.11%47,991
733,333Insider0.08%35,200
395,550Insider0.04%18,986
285,579Insider0.03%13,708

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Antisense Therapeutics Limited (ATHJF)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 2.34% is held by insiders, and 97.66% is held by retail investors.
    What percentage of Antisense Therapeutics Limited (ATHJF) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.00% of Antisense Therapeutics Limited (ATHJF) stock is held by institutional investors.
      What percentage of Antisense Therapeutics Limited (ATHJF) stock is held by retail investors?
      According to the latest TipRanks data, approximately 97.66% of Antisense Therapeutics Limited (ATHJF) stock is held by retail investors.
        Who owns the most shares of Antisense Therapeutics Limited (ATHJF)?
        Robert W Moses owns the most shares of Antisense Therapeutics Limited (ATHJF).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis